The novel proteasome inhibitor NPI-0052 plus TRAIL (TNF related apoptosis inducing ligand) activates the extrinsic apoptotic pathway in pancreatic cancer

被引：0
|
作者：
Sundi, D. [1 ]
Fournier, K. [1 ]
Wray, C. [1 ]
McConkey, D. [1 ]
机构：
[1] MD Anderson Canc Ctr, Houston, TX USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2008年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：70 / 71
页数：2
相关论文
共 50 条
  • [1] Novel NFκB inhibitors NPI-1342 / NPI-1387 and proteasome inhibitor NPI-0052 overcome resistance of pancreatic carcinoma to rhTRAIL
    Khanbolooki, Sanaz
    Pino, Simona
    Andtbacka, Robert
    Chao, Ta-Hsiang
    Neuteboom, Saskia
    Palladino, Michael A.
    McConkey, David J.
    CANCER RESEARCH, 2006, 66 (08)
  • [2] The novel, orally active proteasome inhibitor, NPI-0052, induces apoptosis in leukemia lymphoma cell lines and patient specimens.
    Miller, CP
    Ban, K
    Ruiz, SL
    Neuteboom, S
    Palladino, M
    McConkey, D
    Chandra, J
    BLOOD, 2005, 106 (11) : 74A - 74A
  • [3] Cancer: Novel therapeutic strategies that exploit the TNF-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway
    Cretney, Erika
    Takeda, Kazuyoshi
    Smyth, Mark J.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2007, 39 (02): : 280 - 286
  • [4] Induction of RKIP and inhibition of the transcription repressor YY1 in B-NRL by the novel proteasome inhibitor NPI-0052 and sensitization to TRAIL-Induced apoptosis.
    Suzuki, Eriko
    Huerta-Yepez, Sara
    Baritaki, Stavroula
    Palladino, Michael
    Bonavida, Benjamin
    BLOOD, 2006, 108 (11) : 677A - 677A
  • [5] Multi-level disruption of the extrinsic apoptotic pathway mediates resistance of leukemia cells to TNF-related apoptosis-inducing ligand (TRAIL)
    Leahomschi, S.
    Molinsky, J.
    Klanova, M.
    Andera, L.
    Peterka, M.
    Gasova, Z.
    Klener, P., Sr.
    Trneny, M.
    Necas, E.
    Simonova, T.
    Zivny, J.
    Klener, P., Jr.
    NEOPLASMA, 2013, 60 (02) : 223 - 231
  • [6] NPI-0052, a novel proteasome inhibitor, induces caspase-8 and ROS-dependent apoptosis alone and in combination with HDAC inhibitors in leukemia cells
    Miller, Claudia P.
    Ban, Kechen
    Dujka, Melanie E.
    McConkey, David J.
    Munsell, Mark
    Palladino, Michael
    Chandra, Joya
    BLOOD, 2007, 110 (01) : 267 - 277
  • [7] Requirement of caspase-8 versus caspase-9 during apoptosis in multiple myeloma cells induced by Bortezomib -: Or a novel proteasome inhibitor NPI-0052
    Chauhan, D
    Catley, L
    Velankar, M
    Letai, A
    Hideshima, T
    Podar, K
    Yasui, H
    Mitsiades, N
    Mitsiades, C
    Tai, YT
    Raje, N
    Munshi, N
    Palladino, MA
    Anderson, KC
    BLOOD, 2005, 106 (11) : 944A - 944A
  • [8] The promise of cancer therapeutics targeting the TNF-related apoptosis-inducing ligand and TRAIL receptor pathway
    S Wang
    Oncogene, 2008, 27 : 6207 - 6215
  • [9] The promise of cancer therapeutics targeting the TNF-related apoptosis-inducing ligand and TRAIL receptor pathway
    Wang, S.
    ONCOGENE, 2008, 27 (48) : 6207 - 6215
  • [10] Inhibition of epithelial to mesenchymal transition in metastatic prostate cancer cells by the novel proteasome inhibitor, NPI-0052: pivotal roles of Snail repression and RKIP induction
    Baritaki, S.
    Chapman, A.
    Yeung, K.
    Spandidos, D. A.
    Palladino, M.
    Bonavida, B.
    ONCOGENE, 2009, 28 (40) : 3573 - 3585
12345